References
- Fautrel B., Zing E., Golmard J. L., Le Moel G., Bissery A., Rioux C., et al. Proposal for a new set classification criteria for adult onset Still disease. Medicine (Baltimore) 2002; 81: 194–200
- Masson C., Le Loet X., Liote F., Renou P., Dubost J. J., Boissier M. C., et al. Adult Still's disease: part I. Manifestations and complications in sixty‐five cases in France. Rev Rhum Engl Ed 1995; 62: 748–57
- Yamaguchi M., Ohta A., Tsunematsu T., Kasukawa R., Mizushima Y., Kashiwagi H., et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992; 19: 424–30
- Cavagna L., Caporali R., Epis O., Bobbio‐Pallavicini F., Montecucco C. Infliximab in the treatment of adult Still's disease refractory to conventional therapy. Clin Exp Rheumatol 2001; 19: 329–32
- Hosaka S., Takashina N., Ishikawa A., Kondo H., Kashiwazaki S. Adult Still's disease with myocarditis and peritonitis. Intern Med 1992; 31: 812–15
- Khanna D., McMahon M., Furst D. E. Safety of tumor necrosis factor‐alpha antagonists. Drug Safety 2004; 27: 307–24
- Wojnicz R., Nowalany‐Kozielska E., Wojciechowska C., Glanowska G., Wilczewski P., Niklewski T., et al. Randomized, placebo‐controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two‐year follow‐up results. Circulation 2001; 104: 39–45
- Parrillo J. E. Inflammatory cardiomypathy (myocarditis): which patients should be treated with anti‐inflammatory therapy?. Circulation 2001; 104: 4–6
- Hia C. P. P., Yip W. C. L., Tai B. C., Quek S. C. Immunosuppressive therapy in acute myocarditis: an 18 year systematic review. Arch Dis Child 2004; 89: 580–4